PLM vs eQMS — the two-system tax, and why medtech keeps paying it

Every medical device manufacturer runs two systems that should be one. Product Lifecycle Management holds design intent. Electronic Quality Management holds quality records. They were built by different vendors, for different buyers, at different times, for different problems. They communicate through exports, imports, manual reconciliation, and prayers.

The tax this imposes is real. It shows up in 483 frequency, submission delays, audit scramble, and engineering time lost to documentation reconciliation. Nobody budgets for it explicitly because nobody accounts for it separately. It just shows up as "regulatory friction" and eats a fraction of every engineering program.

What each system was designed for

PLM came out of aerospace, automotive, and industrial manufacturing in the 1990s. The problem it solved was BOM management at scale — thousands of parts, multiple revisions, change propagation across complex assemblies. It's very good at that. Teamcenter, Windchill, Arena, Aras, ENOVIA — the enterprise PLM landscape is mature, and for its original problem it works.

eQMS came out of pharma and device quality departments, also in the 1990s and 2000s. The problem it solved was process enforcement for regulated environments — document control, change control, CAPA workflows, training records. MasterControl, Veeva QualityOne, ETQ Reliance, Greenlight Guru, QT9. Each has a module layout that matches how quality departments organise their own work.

Neither system was designed for the other's use case. PLM wasn't built for CAPA effectiveness verification. eQMS wasn't built for design controls traceability at part-level granularity. Companies that need both — which for medical devices means every company above a few dozen people — end up running both and managing the seams.

Where the seams actually tear

Design controls live half in PLM (design inputs, outputs, BOMs, V&V records) and half in eQMS (design review records, change control approvals, document releases). The same design change event creates entries in both systems. Keeping those entries consistent is manual work.

Risk management lives in one system or the other or a spreadsheet. ISO 14971 requires the risk management file to be a living document linked to design controls. If risk records are in the eQMS and design outputs are in PLM, the link between hazard and design control is reference-only. When the design changes, whether the risk file updates is a matter of process discipline, not system enforcement.

Requirements traceability is the worst of it. Most medical device programs run requirements traceability in a spreadsheet because neither PLM nor eQMS handles requirements linkage cleanly. The spreadsheet — I've seen some that exceed 30,000 rows — ends up as the de facto system of record for what's supposed to be the single most important traceability artefact in the DHF.

Complaint handling and field feedback nominally live in eQMS. The root cause analysis often requires accessing CAD, verification test data, and design history — which live in PLM. Investigators export from one and import to the other, or work from outdated snapshots.

Supplier quality straddles both. Incoming inspection results in one system. Supplier corrective actions in another. The design impact assessment of supplier changes requires both.

What the seams cost

The consulting firms that publish implementation success stories for enterprise PLM and eQMS never include total cost of seam maintenance. Anecdotally — talking with quality directors and VPs of engineering at medical device companies over the last several years — I hear the same numbers. Small companies (under 50 engineers) spend roughly 10–15% of quality team time on inter-system reconciliation. Mid-size companies (50–250 engineers) report 15–25%. Large companies often create dedicated "PLM-QMS integration" roles, which is just formalising the tax as a cost centre.

FDA 483 observation categories reflect the same tax. Design control 483s frequently trace to records that exist in one system but not the other, or that exist in both but disagree. CAPA 483s frequently trace to corrective actions opened in eQMS that never produced corresponding design changes in PLM. Management review 483s frequently trace to quality metrics that aggregate from the two systems with known reconciliation lag.

None of these findings are about companies not caring. They're about companies running two systems that weren't built to share a data model, with a reconciliation discipline that can't scale with program complexity.

The integration vendors' pitch — and why it doesn't fix the problem

Every major PLM has an eQMS partner vendor with a certified integration. Every major eQMS has the same. You can buy a connector between Windchill and MasterControl, or between Teamcenter and Veeva, or between Arena and Greenlight Guru. The integrations work — for the data they're designed to move.

What they don't do is merge the data models. PLM's model of a design change is not the same object as eQMS's model of a change request. The integration maps fields between them. Each system has a view of reality; the integration reconciles the views. That reconciliation is the seam — moved from a manual process to an automated one, but structurally still there.

The failure mode shifts but doesn't disappear. Instead of "the quality team forgot to update eQMS when PLM changed," you get "the integration's field mapping didn't handle the new attribute type correctly" or "the integration ran on schedule but the source data had a race condition." I've seen an integration implementation between Teamcenter and TrackWise that took 18 months, cost north of $2M, and still required manual reconciliation at the month-end close.

What a unified data model changes

When PLM and eQMS share a data model on a single platform, the relationship between a design decision and its quality implications becomes a first-class concept. Not a reference that needs to be maintained. A property of the record.

A design change doesn't trigger a separate change request in eQMS. It is a change request, viewed through the quality lens. The same object shows design engineers the affected BOM items, shows quality engineers the affected CAPA threads, shows regulatory affairs the affected DHF sections, shows manufacturing the affected DMR updates. One object, multiple views, consistent by construction.

This is why MANKAIND was built the way it was. Not because unified PLM-eQMS sounds cleaner on a slide. Because the tax of maintaining the seam between separate systems is a real, measurable, ongoing cost that compounds with program complexity. And because the compliance artefacts that regulators examine — DHF, risk management file, technical file, CAPA effectiveness — are exactly the artefacts that span both systems in traditional architectures.

When separate systems still make sense

The case for separation isn't zero. For manufacturers with deep existing investment in a specific PLM, migrating off a working system has transition costs. For very large enterprises with hundreds of engineers distributed across multiple product lines, the organisational cost of changing core tooling is real.

But the case for separation is weakest exactly where the regulatory stakes are highest — Class III devices, SaMD with post-market surveillance obligations, combination products, AI-enabled devices under PCCP. These programs have the deepest interlock between design decisions and quality evidence, and they're also where separate systems produce the most 483s.

For a new medical device program today, the question isn't whether to run separate PLM and eQMS. It's whether the tax on separation is something you want to carry for the next fifteen years of the product's lifecycle.

Frequently asked questions

What's the difference between PLM and eQMS?

PLM (Product Lifecycle Management) manages design intent — BOMs, CAD, requirements, specifications, verification and validation results. eQMS (electronic Quality Management System) manages quality records — document control, CAPAs, nonconformance reports, complaints, audits, training. Both are typically required for medical device manufacturers. In traditional architectures, they're separate systems from different vendors.

Why should PLM and eQMS be unified?

Design decisions produce quality implications. Keeping the design record and the quality record in separate systems requires manual reconciliation that drifts, produces 483 findings, and adds engineering time to every program. A unified data model makes the relationships between design and quality structural rather than reference-only.

Can I use my existing PLM with an integration to eQMS?

Integration connectors exist between major PLM and eQMS vendors. They move data between systems according to a field mapping. They don't merge the data models. The reconciliation seam moves from manual to automated but remains — failure modes shift from human error to mapping/timing errors, and implementations frequently cost seven figures and take 12–24 months.

Is a unified PLM-eQMS required by FDA?

No. FDA 21 CFR Part 820 specifies outcomes — design controls followed, quality records maintained, CAPAs effective — not architecture. Unified platforms make those outcomes easier to achieve and audit. Separate systems with disciplined integration can satisfy the regulation; they just require more process discipline to avoid the 483 patterns that separation creates.